All sites C00-96,D32-33,D42-43,D45-47,D76 310 86.5 4.6 3.8 1.4 3.7
Mouth, pharynx C00-14 6 100.0 - - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 65 81.7 5.3 5.0 3.1 5.0
  Oesophagus C15 2 100.0 - - - -
  Stomach C16 6 96.7 - - 3.3 -
  Small intestine C17 1 80.0 - - 20.0 -
  Colon C18 20 97.0 - - 1.0 2.0
  Rectum, rectosigmoid C19-20 11 100.0 - - - -
  Anus C21 1 100.0 - - - -
  Liver C22 4 71.4 9.5 19.0 - -
  Gallbladder, bile ducts C23-24 5 60.9 13.0 - 8.7 17.4
  Pancreas C25 13 49.2 19.0 15.9 6.3 9.5
  Other digestive organs C26 2 22.2 - 22.2 11.1 44.4
Respiratory organs C30-39 25 49.2 24.2 15.3 4.8 6.5
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 24 47.1 25.2 16.0 5.0 6.7
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 6 100.0 - - - -
Skin, non-melanoma C44 12 100.0 - - - -
Mesothelioma C45 1 85.7 14.3 - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 91 98.7 0.2 - 0.2 0.9
Female genital organs C51-58 33 95.2 1.8 1.8 0.6 0.6
  Cervix uteri C53 4 94.4 - 5.6 - -
  Corpus uteri C54 16 98.7 1.3 - - -
  Uterus, other C55,C58 0 100.0 - - - -
  Ovary C56 10 89.8 4.1 4.1 - 2.0
  Other female genital C51-52,C57 4 94.4 - - 5.6 -
Urinary organs C64-68 11 94.3 3.8 1.9 - -
  Kidney C64 7 94.1 2.9 2.9 - -
  Bladder and urinary tract2 C65-68 4 94.7 5.3 - - -
Eye C69 - - - - - -
Brain, central nervous system C70-72,D32-33,D42-43 14 68.6 - 14.3 2.9 14.3
Thyroid gland C73 9 95.5 4.5 - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 8 43.6 15.4 17.9 2.6 20.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 27 82.5 7.3 2.2 0.7 7.3
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 12 98.4 - - - 1.6
  Malignant immunoproliferative diseases C88 0 50.0 - 50.0 - -
  Myeloma and other plasma cell tumors C90 6 67.9 14.3 3.6 3.6 10.7
  Leukaemia C91-95 5 68.0 24.0 4.0 - 4.0
  Myelodysplastic syndromes D46 1 40.0 - - - 60.0
  Myeloproliferaitive neoplasms D45,D47 2 83.3 - - - 16.7
Not included above
  Carcinoma in situ of the breast D05 13 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 15 100.0 - - - -
  Borderline tumour of the ovary D39 4 94.7 - - - 5.3
  Basal cell carcinoma of the skin 69 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.